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Abstract 
 
Introduction: Improvements in the 6-minute walk test (6MWT) distance is a key outcome measure 
following a cardiovascular prevention and rehabilitation programme (CPRP). In the absence of a 
practice test, reporting metres scored in isolation lacks reliability as walking performance has been 
shown to be influenced by the test-retest learning effects. Therefore, we employed a more robust 
evaluation using the heart rate walking speed index (HRWSI) to determine if the improvement in 
6MWT distance following a CPRP is related to a true physiological adaptation. 
 
Methods: 39 patients (21 female), mean age 68.2 ± 9.8 years attended a 12 week MyAction CPRP. All 
were assessed using the 6MWT on the initial and end of programme (EOP) assessment. Heart rate 
(HR), rating of perceived exertion (RPE) and the HRWSI were measured. HRWSI was calculated by 
dividing HR by the walking speed (meters per minute) multiplied by 10 to describe heart beats per 
10 metres walked.    
 
Results: Following the MyAction CPRP there was a 40 metre (17%) improvement in the 6MWT 
distance (95% CI 18.8-50 p=<0.001) with a subsequent reduction in the HRWSI (-2.7 + IQR -0.59 to 0 
95% CI -0.4-0.8 p<0.001). There was a non-significant change in peak HR (-0.4 bpm 95% CI -1.8-2.6 
p=0.69) and RPE (0 95% CI 0-1 p= 0.4) between the initial and EOP assessments.  
 
Conclusions: The use of the HRWSI provides transparency on the physiological adaptations following 
a CPRP and can also be used to help patients recognise the benefits of exercise training. For 
example, the average patient increased his/her 6MWT distance by 40 metres and decreased their 
HRWSI by 2.7, which translates in a saving of 3 heart beats for every 100 metres walked or 45 heart 
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Cardiovascular prevention and rehabilitation programmes (CPRP) are an evidence-based 
intervention, which reduces cardiovascular mortality, hospital readmissions and it improves quality 
of life (Anderson et al 2015). Traditionally, exercise training has been the ‘glue’ to most CPRP as 
gains in cardiorespiratory fitness have been associated with several positive health outcomes (Dorn 
et al 1999, Myers et al 2002, Kodama et al 2009). Furthermore, formal evaluations of 
cardiorespiratory fitness are core to most national and international guidelines (BACPR 2007, Piepoli 
et al 2014). The choice of cardiorespiratory fitness test is dependent on cost, operator experience, 
space, time and the participant’s comorbidities and baseline fitness levels. In many countries 
maximal exercise testing is performed using open-circuit spirometry whilst exercising on a treadmill 
or cycle ergometer (Guazzi et al 2012). Whilst open-circuit spirometry is considered as the gold 
standard, typically this type of exercise test is normally performed at baseline and is rarely used to 
measure changes in cardiorespiratory fitness over time. 
As an alternative, the Association of Chartered Physiotherapists in Cardiac Rehabilitation  
recommend using a functional capacity test, such as a walk test or step test, as a more practical, cost 
effective means of assessing cardiorespiratory fitness following a CPRP (ACPICR 2015). Walk tests 
such as the incremental shuttle walk test and the 6-minute walk test (6MWT) typically report 
changes in distance achieved; whereas step tests (Chester Step test) report changes in terms of 
predicted oxygen uptake (Holland et al 2014 and Sykes 1998). Both these types of functional 
capacity tests have been used extensively in patients at high risk of cardiovascular disease and in 
those with established vascular disease (Connolly et al 2017, Grove et al 2017). However, due to the 
progressive nature of the incremental shuttle walk test and the Chester Step test they are more 
suited to patients with higher baseline cardiorespiratory levels. For patients with a low functional 
capacity the self-paced 6MWT is more appropriate and closely resembles submaximal effort, which 
is related to daily living activities.  
 
The 6MWT originated from the 12-minute walk test and was designed to measure the functional 
capacity in patients with respiratory disease (Butland 1982, Macgavin et al 1976). Since its 
introduction, it has been used in patients with various types of cardiovascular disease (Bellet et al 
2012, Dunn et al 2015). The main aim of the 6MWT is for the individual to walk as far as possible 
back and forth or around a 30-metre track at their own pace and they are able to stop and rest as 
required (Holland et al 2014). The 6MWT correlates well with symptom-limited exercise testing 
(r=0.56 to 0.93), physical function subscales of the SF-36 (r = 0.624) and it is responsive to measuring 
change (60.43m 95% CI 54.57 to 66.30 m) following a CPRP (Guyatt et al 1985, Faggiano et al 1997, 
Hamilton and Haennel 2000, Bellet et al 2012). However, in the absence of a practice test, the 
6MWT can overestimate the change in walk distance due to the learning effect following an exercise 
intervention by as much as 2 to 8% (Bellet et al 2012). Therefore, an 8% improvement could 
potentially be as much as 24 metres in patients achieving >300 metres on the 6MWT. In order to 
eliminate the learning affect, Buckley et al (2010) have recommended applying the heart rate 
walking speed index (HRWSI) to tease out the physiological adaptations from other reasons for 
improvements in walk distance. The HRWSI is the ratio between heart rate (HR) at given walking 
speed (meters per minute) multiplied by 10 to describe heart beats per 10 metres walked. The 
HRWSI has been used in post-MI and coronary revascularization patients during the incremental 
shuttle walk test following a cardiac rehabilitation programme (Buckley et al 2010). However to 
date, it has not been used to assess the physiological adaptations during the 6MWT in patients at 
high risk of cardiovascular disease (CVD) and in patients with established atherosclerotic disease 
including acute coronary syndrome, cerebral vascular disease and peripheral artery disease. 
Therefore the primary aim of this study is to assess the changes in 6MWT distance and HRWSI in 






This was a service evaluation study designed to establish a change in walking distance on the 6MWT, 
HRWSI, HR, and rating of perceived exertion (RPE) following the Westminster MyAction CPRP. The 
MyAction programme is an innovative nurse-lead multidisciplinary community-based CPRP, which 
provides integrated care to those with established cardiovascular disease as well as those identified 
to be at high multifactorial risk (QRisk2> 15%) through the NHS Health Checks programme. The 
MyAction programme was founded on the principles of the successful EUROACTION cluster 
randomised-controlled trial (Wood et al 2008). Data were collected on patients who attended their 
initial and end of programme assessment at the Imperial College NHS Healthcare Trust between 
September 2009 and October 2015. 
 
Methods and methodology  
 
Patients attended an initial assessment (IA) and an end of programme assessment (EOP) after 12 
weeks of a once weekly exercise and educational session. At IA, patients were assessed by a Cardiac 
Specialist Nurse, Dietitain and an Exercise Specialist. During the assessments the patients were 
interviewed about their medical history, smoking habits, dietary habits using the Mediterranean diet 
score and their physical activity behaviours using a 7-day physical activity diary and their physical 
function using a subscale of SF-36 questionnaire. As part of the assessment, objective measures 
were taken including: carbon monoxide testing, basic anthropometric measurements (body mass 
index (BMI), weight and waist circumference) medical history, blood pressure, lipid and glucose 
profiles, and a functional capacity test. The functional capacity test included the Chester Step test for 
patients with higher predicted baseline fitness levels or the 6MWT for patients who were predicted 
to have a low functional capacity. The choice of test was determined from the patient’s subjective 
responses to the physical function subscale of SF-36 questionnaire.  This study will only focus on the 
results of the 6MWT.   
 
6-minute walk test 
 
Before each 6MWT the patients were asked to refrain from eating, smoking or drinking caffeinated 
drinks for at least 2 hours before their assessment and they were instructed to take all prescribed 
medication as normal. The patients were also asked not to take part any moderate or vigorous 
exercise for 24 hours prior to 6MWT to ensure a consistent baseline activity levels.  The patients 
were fitted with a HR monitor and the Borg 6-20 RPE scale was explained and ‘anchored’ (Borg 
1998). RPE is a validated subjective tool that is used to estimate the patient’s global perception of 
effort. The instructions given to the patients was to focus on overall exertion and not exertion of a 
particular body part. Before commencing the 6MWT the patients rested, had their blood pressure 
and HR measured and they were instructed on the protocol described in box 1. Figure 1 presents the 
6MWT. Due to limited clinic space the 6MWT course was 10 metres long. During the 6MWT the 
patient’s HR and RPE score were recorded at each minute.  HRWSI was calculated by dividing HR by 
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Exercise intervention  
The patients attended a community or hospital-based supervised circuit training session once per 
week for up to 12 weeks and they were encouraged to take part in a home exercise programme or 
an exercise DVD two –three times per week. The supervised circuit consisted of a 15 minute warm-
up, 20-24 minutes of circuit interval training comprised of aerobic and low-intensity resistance 
exercises and a 10 minute cool-down. For some patients the circuit interval training programme 
consisted of chair-based or supported exercise stations. During the training programme, the patients 
exercised at an intensity range of between 40 and 60% of their age predicted HR reserve max and/or 
at an RPE of 11 to 13, as recommended by the ACPICR (2015) guidelines. Over the 12 weeks, the 
exercise programme was progressed on the basis of increasing the duration of time spent on the 
aerobic exercise stations and decreasing the time spent on the resistance exercise stations until 20-
24 minutes of continuous aerobic exercise was achieved. In addition, at the end of each exercise 
session, the patients attended a 45-minute weekly educational workshop on CVD risk factor 
modification, smoking cessation, cardio-protective medication, stress management, benefits of 
physical activity, food labelling and the Mediterranean diet. 
  
Statistical methods 
All data was assessed for parametric assumptions prior to statistical analysis using Stata version 
13.0. Parametric data are expressed as mean ± standard deviation (sd) and non-parametric data are 
expressed as median ± interquartile range (IQR). The Wilcoxon signed rank test are conducted on the 
6MWT distance and RPE, Paired t tests for HR and the Sign rank test are conducted on the HRWSI. A 
sub-group analysis was carried out, which compares the 6MWT distance, HRWSI, HR and RPE 
between those at high risk and in patients with CVD.  
Results:  
A total of 1810 patients attended an IA and EOP assessment over a 6 year period. Out of the 1810 
patients, 45 patients were identified as having a low predicted baseline fitness level and they took 
part in the 6MWT. From the 45 patients, 2 patients were excluded from the analysis due to missing 
HR data on the 6MWT and 4 patients were excluded due to changes in their beta-blocker dose 
following their IA. The final analysis included 39 patients (21 female), mean age 68.2 ± 9.8 years 
(range 48 to 93 years) who attended a 12 week Westminster MyAction programme (mean 11 
exercise sessions range 8-14). Out of the 39 patients, 18 patients were stratified as high 
multifactorial risk (26.9% ± 7.1 risk score) and 21 had established CVD. In addition, 95% of the 
patients presented with one or more co-morbidities (range 0-5). Demographics are presented in 
table 1. 
Changes in 6-minute walk test distance 
At the EOP assessment, the median 6MWT distance had increased by 40 metres + IQR 0-70 metres 
(95% CI 18.8-50 p=<0.001) following the MyAction programme (table 2). The median distance 
achieved was slightly greater in those who had established CVD when compared to the patients at 
high multi-factorial risk, although this was not significant (p=0.8) figure 2.  
 
 
Changes in heart rate walking speed index 
In support of an increase in the 6MWT distance the HRWSI had significantly decreased by -2.7 + IQR -
5.8 to 0 (95% CI -3.5,-0.4 p<0.001) at the EOP assessment (table 2). In a sub-group analysis there 
were no significant differences in the decrease in the HRWSI between patients at high risk and in 
patients with established CVD (p=0.8).  
Changes in heart rate 
The overall peak HR response was similar between the IA and EOP assessment 6MWTs (-0.4 bpm 
95% CI -1.8-2.6 p=0.69) (table 2). In a subgroup analysis, the high risk patients decreased their 
exercise HR from 104.4±14 beats/min to 102.6±13 beats/min at EOP assessment (-1.7 95% CI -0.7-
4.2 p=0.15) and patients with CVD had a slight increase in their exercise HR response from 94.1±17 
beats/min to 94.8±17 beats/min (0.7 95% CI -4.4-3 p=0.69) at EOP assessment. The change in HR 
response between the two groups was non-significant (p=0.05) 
Changes in rating of perceived exertion 
Overall RPE did not significantly change and the median score was 0 + IQR 0 to 1 (95% CI 0-1 p= 0.4) 
(table 2). In a subgroup analysis, the median RPE score was 0 + IQR 0-2 and 0 + IQR -1-2 respectively 
for patients at high risk and patients with CVD. There were no significant differences between the 
two groups (p=0.2) 
Discussion 
The aim of this study was to assess the changes in 6MWT distance, HRWSI, HR and RPE following the 
Westminster MyAction CPRP. The results demonstrated that walking performance on the 6MWT had 
significantly increased by 40 metres + IQR 0-70 metres at the EOP assessment (95% CI 18.8-50 
p=<0.001). In a sub-group analysis, patients with established CVD achieved a greater improvement in 
their median distance when compared to patients at high risk (40 metres vs 35 metres), although 
this was not statistically significant (p=0.8). Overall, 72% (n=28) of the patients had increased their 
6MWT distance (range 10 to 265 metres), 15% (n=6) had remained the same and 13% (n=5) had a 
decrease in their 6MWT distance (-10 to -80 metres) following the MyAction programme. However, 
the overall median change in distance of 40 metres is less than the 60.43 metres that has been 
previously reported in a recent meta-analysis (Bellet et al 2012). These differences are probably due 
to the fact that the present study reported on the median change in distance and the 6MWT course 
length was set at 10 metres. According to guidelines the standard course length should be at least 30 
metres (Crapo et al 2002, Holland et al 2014); however, due to limited clinic space a shorter course 
length of 10 metres was used at the initial and EOP assessments. Therefore, it should be noted that 
on average patients walk 49.5 metres less on a 10 metre course when compared to a 30 metre 
course (Beekman et al 2013). In addition, many other factors might have also influenced the distance 
that was achieved during the 6MWT and these include: age, body mass, gender, additional co-
morbidities, stride length, motivation, and the test-retest learning effect (Crapo et al 2002, Beekman 
et al 2013, Garyfallia et al 2013).  The following will discuss the factors relating to motivation and the 
test-retest learning effect. 
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Motivation can be influenced internally by the patient (i.e. patient remembering their pre-test 
distance and trying to do better on their post-test) or externally through encouragement from the 
tester. In order to minimise the internal factors, patients were only reminded of their IA 6MWT 
distance once they had completed their EOP 6MWT. For external motivation, standardised 
encouragement from the test administrator was given every two minutes such as “you are doing 
well” and “keep it up”. Encouragement can increase the mean walking distance by 30.5 metres 
compared to no encouragement (Guyatt et al 1984).  
With regards to the test-retest learning effect this can be reduced by performing a practice test. 
However, in the present study it was not possible to conduct a practice test due to time constraints 
and the extra burden that would have been placed on the patients if they had to attend additional 
assessments on different days. In light of the current evidence, Hamilton and Haennel (2000) and 
Bellet et al (2012) have reported a 2-8% improvement following a practice test and Guyatt et al 
(1984) have observed a plateau in the performance on the 6MWT following 3 consecutive tests. 
Therefore, it could be argued that a 22 metre (8%) improvement in the present study could be 
accounted for by the learning effect. Nonetheless, to contest this argument the HRWSI was applied 
to measure the physiological adaptations following the MyAction programme. The HRWSI is the 
ratio between HR at given walking speed (meters per minute) multiplied by 10 to describe heart 
beats per 10 metres walked (Buckley et al 2010). In the present study the HRWSI decreased by 2.7 + 
IQR -0.59 to 0 (95% CI -0.4-0.8 p<0.001). These findings translate into a saving of 3 heart beats for 
every 100 metres walked or 45 heart beats for every mile walked. Moreover, for patients who lie 
within the interquartile range the saving could be as much 6 heart beats for every 100 metres 
walked or 90 heart beats for every mile walked.  These findings are similar to Buckley et al’s (2010) 
study, who observed a saving of 4 heart beats for every 100 metres walked or 60 heart beats for 
every mile walked in patients taking part in the incremental shuttle walk test following a cardiac 
rehabilitation programme.  
The reduction in HR at a given workload is a classical training adaptation, which reflects an 
improvement in cardiac efficiency. Such improvements can reduce the rate pressure product, 
myocardial ischaemia and the risk of arrhythmias (Malfatto et al 1996, May et al 1984). The 
magnitude that is associated with the reduction in submaximal HR response is dependent on the 
exercise training intensity and volume. This was demonstrated by a 7–14 bpm reduction in 
submaximal HR response in 140 patients with an abdominal aortic aneurysm following a high 
exercise volume (1,999 ± 1,030 kcal/week energy expenditure) and a high intensity (98.8% of HR 
training zone) exercise training programme (Myers et al 2014). In addition, lower intensity exercise 
training programmes (40-70% of predicted HR reserve max) can also provoke a 4-7 bpm reduction in 
submaximal HR response following a training intervention in those at high risk of CVD and with 
established vascular disease (Grove et al 2017). 
In support of the reduction in both HRWSI and HR responses, RPE was used to assess the overall 
global perception of effort during the 6MWT. The use of RPE is widely accepted as a valid and 
reliable method for assessing exercise intensity as it correlates well with HR, oxygen uptake and the 
lactate threshold (Chen et al 2002). At the EOP assessment RPE did not significantly change despite 
an increase in walking distance (0 95% CI 0-1 p=0.4). This clearly demonstrates that patients at the 
EOP assessment are able to accomplish a greater workload with a similar perception of exertion and 
physiological demand.  
 
Limitations  
Despite the positive outcomes of the present study, it is important to acknowledge the main study 
limitations. The first limitation is related to the data, which was collected from clinical practice with 
no control group and it needs to be verified in a randomised prospective study design. The second 
limitation is related to HR, which was recorded on the database as peak rather than the average 
during the 6MWT. The third limitation relates to medication compliance, which was only assessed 
subjectively and not objectively. Therefore, poor compliance with heart rate limiting medication 
such as beta blockade therapy could alter the HR response during the 6MWT. The fourth limitation 
relates to extrinsic variables such as room temperature was not controlled, which could potentially 
influence the HR response during the 6MWT. Future research is needed to control for these 




The results of this study demonstrated that the Westminster MyAction CPRP is an effective 
intervention for improving 6MWT distance, HRWSI and physical function in patients at high risk of 
CVD and in patients with established vascular disease. Following the programme there was a 14% 
improvement in the 6MWT distance with a subsequent 2.7 + IQR -0.58 to 0 reduction in the HRWSI. 
The use of the HRWSI provides transparency on the physiological adaptations following a CPRP and 
can also be used to help patients recognise the benefits of exercise training. For example, the 
average patient increased his/her median 6MWT distance by 40 metres and decreased their HRWSI, 
which translates in a saving of 3 heart beats for every 100 metres walked or 45 heart beats for every 
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Box 1. 6-minute walk test protocol 
 
Two cones were set out 9 metres apart, which allowed for a 0.5 metre turn at each end giving a total 
distance of 10 metres. Chairs were placed at either end of the course. The patients were instructed   
to cover as much distance as possible within 6 minutes by walking back and forth around the course 
pivoting 1800 at each cone. The test administrator demonstrated by walking one lap around the 
course and pivoting around the cones. During the 6MWT patients were able to rest when needed 
and recommence when they felt able to. Patients were able to take part in the test using a walking 
aid. Standardised verbal encouragement was given to the patients every 2 minutes. HR and RPE were 
recorded each minute during the test. After 6 minutes patients were instructed to stop and the total 
distance achieved was recorded.  
 

















Age, mean ± SD (yr) 
Gender (n % male) 
Ethnicity (n % Caucasian) 
BMI, mean ± SD (kg.m-2) 
Waist, mean ± SD (cm) 
No. exercise sessions mean (range) 
Summary 





11±  (range 8-14) 
Diagnosis on referral n (%) 















Co-morbidities n (%) 
Asthma/COPD  
Cancer  
Chronic back pain  
CVA/TIA  
Diabetes   
Previous cardiac events   
Atrial septal defect  
Rheumatoid/osteoarthritis  
Osteoporosis  


































Table 2. Changes in 6MWT distance, HRWSI, HR and RPE 
 









Peak heart rate 
(mean + SD) 
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